Back to 
NORTHERN TRUST CORP
NORTHERN TRUST CORP
CLDXShowing 8 of 30 quarters
Position history for NORTHERN TRUST CORP's holdings in Celldex Therapeutics, Inc.
NORTHERN TRUST CORP holds 719,647 shares of CLDX (Celldex Therapeutics, Inc.), worth $26.8M as of 2026-Q2. The position was increased (+24.7% shares). CLDX represents 0.0% of NORTHERN TRUST CORP's portfolio.
Current Value
$26.8M
Current Shares
719,647
Total Value Change
+$7.7M
Total Shares Change
+156,927
Quarter-by-Quarter History
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP